Laurent David
11Patents
4h-index
25Co-inventors
52Inventor score
Filing activity: Dec 30, 2013 → Aug 11, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10487142B2 | Antibodies specific for hyperphosphorylated tau and methods of use thereof | Physics | 5 | Active |
| US10647762B2 | Antibodies specific for hyperphosphorylated tau and methods of use thereof | Physics | 5 | Active |
| US10472415B2 | Antibodies specific for hyperphosphorylated tau and methods of use | Physics | 5 | Active |
| US11111290B2 | Antibodies specific for hyperphosphorylated tau and methods of use thereof | Physics | 4 | Active |
| US11358971B2 | Prodrugs of modulators of the NMDA receptor | Human Necessities | 1 | Active |
| US9682967B2 | N-substituted-5-substituted phthalamic acids as sortilin inhibitors | Chemistry; Metallurgy | 1 | Active |
| US9393248B1 | Aminopyridine derived compounds as LRRK2 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US12129289B2 | Antibodies specific for hyperphosphorylated tau and methods of use thereof | Physics | 0 | Active |
| US9321748B2 | Aminopyridine derived compounds as LRRK2 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10195186B2 | N-substituted-5-substituted phthalamic acids as sortilin inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11466027B2 | Modulators of the NMDA receptor | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.